The Ministry of Health and Prevention (MoHAP) on Monday (September 14) announced the emergency approval for use of the COVID-19 vaccine.
The UAE’s ongoing vaccine trials have reached a new milestone with no reported complications among individuals tested with chronic diseases.
Covid-19 Vaccine on Trial Approved by UAE Gov’t Following Complication-Free Testing Among Patients with Chronic Conditions
According to Dr. Nawal Al-Kaabi, Chairman of the National Clinical Committee for Coronavirus, and the principal investigator for the world’s first-ever Phase III inactivated COVID-19 vaccine clinical trials, “1,000 of the UAE’s 31,000 volunteers were individuals who had chronic illnesses and not a single one of them felt any complications when they took the vaccine,” the Gulf News reported.
In line with this, Abdul Rahman Al Owais, Minister of Health and Community Protection said that the approval of the vaccine was given upon meeting set criteria for this specific purpose and working closely with the vaccine’s developers.
The evaluation was conducted under a license for emergency and limited use, considering target groups, product characteristics, clinical studies data, and all relevant available scientific evidence.
Owais added that health authorities have followed all procedures to control the quality, safety and efficacy of the vaccine in coordination with the vaccine’s creators.
“The vaccine will be available to our first line of defense heroes who are at the highest risk of contracting the viruto to protect them from any dangers and provide safety precautions,” he announced.
The emergency aapproval for the use of the vaccine is fully aligned with regulations and laws, which permit accelerated authorisation process.
He added that the results of the first and second test phases showed that the vaccine was safe, effective and triggered the right response.
The third phase of the vaccine clinical trials in the UAE are progressing at a steady pace under the strict supervision of medical teams, while following all measures to control the quality, safety and efficacy of the vaccine.
Owais said, “Through these steps, we aim to contribute to saving the lives of millions of people and provide health care for the infected.”
He reported that the results of clinical trials in the country are moving on the right path, with all tests being successful so far.
In less than six weeks since the trials began, 31,000 volunteers representing 125 nationalities have participated in the study.
ALSO READ: COVID-19 Swab Tests Now at AED 250 in Dubai